New Perspectives on Atherogenic Dyslipidaemia and Cardiovascular Disease
Over the past few decades, atherogenic dyslipidaemia has become one of the most common phenotypic presentations of lipid abnormalities, being strongly and unequivocally associated with an increased risk of cardiovascular (CV) disease. Despite the excellent results achieved from statin and non-statin...
Saved in:
| Main Authors: | Alberto J Lorenzatti, Peter P Toth |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Radcliffe Medical Media
2020-02-01
|
| Series: | European Cardiology Review |
| Online Access: | https://www.ecrjournal.com/articleindex/ecr.2019.06 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Acetate alleviates glucose dysregulation and atherogenic dyslipidaemia in experimentally induced PCOS
by: STEPHANIE ESOSA JOY ARELOEGBE, et al.
Published: (2025-06-01) -
Non- high-density lipoprotein cholesterol and cardiovascular disease in patients with diabetic dyslipidaemia
by: Alberto Zambon
Published: (2020-04-01) -
Relationship between Atherogenic Dyslipidaemia and Lipid Triad with Different Scales of Overweight and Obesity in 418,343 Spanish Workers
by: Carla Busquets-Cortés, et al.
Published: (2022-01-01) -
Dyslipidaemia in patients with chronic kidney disease – a neglected cardiovascular risk factor
by: M R Essop, et al.
Published: (2023-11-01) -
Secondary dyslipidaemia
by: D.J. Blom
Published: (2011-07-01)